SARAH FRANK: Open Payments
NPI 1760867014 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,490 in 46 payments from 18 companies in 2025. Trend: 2023 $339 · 2024 $1,069 · 2025 $1,490
Food & beverage: $1,490
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $390 |
| AstraZeneca Pharmaceuticals LP | 6 | $334 |
| Amgen Inc. | 2 | $163 |
| ABBVIE INC. | 8 | $147 |
| Axsome Therapeutics, Inc. | 2 | $127 |
| Xeris Pharmaceuticals, Inc. | 1 | $46 |
| Astellas Pharma US Inc | 2 | $37 |
| Dexcom, Inc. | 2 | $35 |
| ABIOMED | 1 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $30 |
Products named: Wegovy, Ozempic, BREZTRI, AIRSUPRA, REPATHA, Auvelity, VRAYLAR, KEVEYIS.
Industry payments across NC — which companies pay providers there.
